{description}It is estimated that over 106,000 people die every year because they are given the wrong dose of medicine. Adverse Drug Reactions (ADRs) are a signifcant problem in today’s health care industry, hospitalizing an estimated 2.2 million people each year. It is the fourth leading cause of death in the U.S.—ranking signifcantly higher than AIDS, pulmonary disease and diabetes.  Before you become wary of taking your next medication, there is good news. Scientists have made progress in personalized medicine, the identifcation of drug treatments based upon an individual’s genetic profle. While revolutionary, personalized medicine has profound ethical implications. Dr. David Magnus, Director of the Stanford Center for Biomedical Ethics, reveals the ethical considerations at stake with personalized medicine. {/description}